The DOI matches its Crossref record; 191 of the 191 references it cites were found in a registry or an index.
Mouse models for human lung cancer
Open accessAbstract
In recent years several new mouse models for lung cancer have been described. These include models for both non-small-cell lung cancer (NSCLC) and small-cell lung cancer (SCLC). Tumorigenesis in these conditional mouse tumor models can be initiated in adult mice through Cre-recombinase-induced activation of oncogenic mutations in a subset of the cells. They present a marked improvement over mouse models that depend on carcinogen induction of tumors. These models permit us to study the consecutive steps involved in initiation and progression and allow us to address questions like the cell of origin, and the role of cancer stem cells in the maintenance of these tumors. They now need to be validated as suitable preclinical models for intervention studies in which questions with respect to therapy response and resistance can be addressed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486 · cited 4×
“A subgroup of patients with NSCLC carry these specific mutations in EGFR that causes them to clinically respond to Iressa (Lynch et al. 2004; Paez et al. 2004).”
InfluentialEGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Mortality in relation to smoking: 40 years' observations on male British doctors
Doll, R., Peto, R., Wheatley, K., Gray, R., & Sutherland, I. (1994) · BMJ · doi:10.1136/bmj.309.6959.901 · Cited by 5,932
Tight control of gene expression in mammalian cells by tetracycline-responsive promoters.
Gossen, M., & Bujard, H. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.12.5547 · Cited by 4,943 · cited 1×
“Thus, specific gene expression in these bitransgenic mice can be switched on or off by administration and withdrawal of doxycycline (Gossen and Bujard 1992).”
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Jemal, A., Tiwari, R. C., Murray, T., Ghafoor, A., Samuels, A., Ward, E., Feuer, E. J., & Thun, M. J. (2004) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.54.1.8 · Cited by 3,984
Landis, S. H., Murray, T., Bolden, S., & Wingo, P. A. (1999) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.8 · Cited by 3,068
Mortality in relation to smoking: 50 years' observations on male British doctors
Doll, R., Peto, R., Boreham, J., & Sutherland, I. (2004) · BMJ · doi:10.1136/bmj.38142.554479.ae · Cited by 2,920 · cited 1×
“Although smoking cessation before the age of 30 does substantially reduce the risk of lung cancer, this is significantly less for those who stop smoking at 50 or 60 yr (Peto et al. 2000; Doll et al. 2004).”
Bhattacharjee, A., Richards, W. G., Staunton, J., Li, C., Monti, S., Vasa, P., Ladd, C., Beheshti, J., Bueno, R., Gillette, M., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191502998 · Cited by 2,576
DNA double-strand breaks: signaling, repair and the cancer connection
Khanna, K. K., & Jackson, S. P. (2001) · Nature Genetics · doi:10.1038/85798 · Cited by 2,455
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Massoud, T. F., & Gambhir, S. S. (2003) · Genes & Development · doi:10.1101/gad.1047403 · Cited by 2,216
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
Inducible Gene Targeting in Mice
Kühn, R., Schwenk, F., Aguet, M., & Rajewsky, K. (1995) · Science · doi:10.1126/science.7660125 · Cited by 1,641
Changing views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,588
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
Peto, R. (2000) · BMJ · doi:10.1136/bmj.321.7257.323 · Cited by 1,409
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
Sahai, E., & Marshall, C. J. (2002) · Nature Reviews Cancer · doi:10.1038/nrc725 · Cited by 1,261
Esteller, M., Hamilton, S. R., Burger, P. C., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 1,253
p53: A Frequent Target for Genetic Abnormalities in Lung Cancer
Takahashi, T., Nau, M. M., Chiba, I., Birrer, M. J., Rosenberg, R. K., Vinocour, M., Levitt, M., Pass, H., Gazdar, A. F., & Minna, J. D. (1989) · Science · doi:10.1126/science.2554494 · Cited by 1,197
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., & Jacks, T. (2001) · Nature · doi:10.1038/35074129 · Cited by 1,179
The insulin-like growth factor system and cancer
LeRoith, D., & Roberts, C. T. (2003) · Cancer Letters · doi:10.1016/s0304-3835(03)00159-9 · Cited by 1,124
Tobacco smoke carcinogens, DNA damage and p53 mutations in smoking-associated cancers
Pfeifer, G. P., Denissenko, M. F., Olivier, M., Tretyakova, N., Hecht, S. S., & Hainaut, P. (2002) · Oncogene · doi:10.1038/sj.onc.1205803 · Cited by 1,112
Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer
Watkins, D. N., Berman, D. M., Burkholder, S. G., Wang, B., Beachy, P. A., & Baylin, S. B. (2003) · Nature · doi:10.1038/nature01493 · Cited by 1,082
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome
Lang, G. A., Iwakuma, T., Suh, Y.-A., Liu, G., Rao, V. A., Parant, J. M., Valentin-Vega, Y. A., Terzian, T., Caldwell, L. C., Strong, L. C., et al. (2004) · Cell · doi:10.1016/j.cell.2004.11.006 · Cited by 1,069 · cited 1×
“These data strongly suggest that Tp53 point mutations found in human cancer show enhanced oncogenicity as compared to conventional Tp53 loss (Lang et al. 2004; Olive et al. 2004).”
Dammann, R., Li, C., Yoon, J.-H., Chin, P. L., Bates, S., & Pfeifer, G. P. (2000) · Nature Genetics · doi:10.1038/77083 · Cited by 1,064
Jonkers, J., Meuwissen, R., van der Gulden, H., Peterse, H., van der Valk, M., & Berns, A. (2001) · Nature Genetics · doi:10.1038/ng747 · Cited by 1,053
Self-citationGu, H., Zou, Y.-R., & Rajewsky, K. (1993) · Cell · doi:10.1016/0092-8674(93)90644-6 · Cited by 989
Ciardiello, F., Caputo, R., Bianco, R., Damiano, Pomatico, G., De Placido, S., Bianco, A. R., & Tortora, G. (2000) · PubMed · Cited by 943
Esteller, M., Sánchez‐Céspedes, M., Rosell, R., Sidransky, D., Baylin, S. B., & Herman, J. G. (1999) · PubMed · Cited by 921
Marino, S., Vooijs, M., van der Gulden, H., Jonkers, J., & Berns, A. (2000) · Genes & Development · doi:10.1101/gad.14.8.994 · Cited by 920
Self-citationK-ras Oncogene Activation as a Prognostic Marker in Adenocarcinoma of the Lung
Slebos, R. J. C., Kibbelaar, R. E., Dalesio, O., Kooistra, A., Stam, J., Meijer, C. J. L. M., Wagenaar, S. S., Vanderschueren, R. G. J. R. A., van Zandwijk, N., Mooi, W. J., et al. (1990) · New England Journal of Medicine · doi:10.1056/nejm199008303230902 · Cited by 809
Epigenetic Inactivation of RASSF1A in Lung and Breast Cancers and Malignant Phenotype Suppression
Burbee, D. G., Forgacs, E., Zochbauer-Muller, S., Shivakumar, L., Fong, K., Gao, B., Randle, D., Kondo, M., Virmani, A., Bader, S., et al. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.9.691 · Cited by 769
The retinoblastoma tumour suppressor in development and cancer
Classon, M., & Harlow, E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc950 · Cited by 738
bcl-2 Protein in Non-Small-Cell Lung Carcinoma
Pezzella, F., Turley, H., Kuzu, I., Tungekar, M. F., Dunnill, M. S., Pierce, C. B., Harris, A., Gatter, K. C., & Mason, D. Y. (1993) · New England Journal of Medicine · doi:10.1056/nejm199309023291003 · Cited by 671
Travis, W. D. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00061-3 · Cited by 655
Meuwissen, R., Linn, S. C., Linnoila, R. I., Zevenhoven, J., Mooi, W. J., & Berns, A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00220-4 · Cited by 643 · cited 5×
“These were invariably adenocarcinomas with NSCLC features (Meuwissen et al. 2003).”
InfluentialSelf-citationFisher, G. H., Wellen, S. L., Klimstra, D., Lenczowski, J. M., Tichelaar, J. W., Lizak, M. J., Whitsett, J. A., Koretsky, A., & Varmus, H. E. (2001) · Genes & Development · doi:10.1101/gad.947701 · Cited by 582 · cited 6×
“In fact, MRI was used to image lung tumor regression in the above-described CCSP-rtTA/ (tetO7)CMV-K-Ras4 G12D mouse model (Fisher et al. 2001).”
InfluentialTravis, W. D., Travis, L. B., & Devesa, S. S. (1995) · Cancer · doi:10.1002/1097-0142(19950101)75:1+<191::aid-cncr2820751307>3.0.co;2-y · Cited by 582
Tumor induction by an endogenous K-ras oncogene is highly dependent on cellular context
Guerra, C., Mijimolle, N., Dhawahir, A., Dubus, P., Barradas, M., Serrano, M., Campuzano, V., & Barbacid, M. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00191-0 · Cited by 571
Loss of p16Ink4a confers susceptibility to metastatic melanoma in mice
Krimpenfort, P., Quon, K. C., Mooi, W. J., Loonstra, A., & Berns, A. (2001) · Nature · doi:10.1038/35092584 · Cited by 568 · cited 2×
“As a starting point, one might use mice that combine a conditional K-Ras or Myc oncogene with conditional tumor-suppressor genes such as Trp53 or p16Ink4a/p19ARF (Vooijs et al. 1998; Jonkers et al. 2001; Krimpenfort et al. 2001; Jonkers and Berns 2002) that are frequently mutated in lung tumors.”
Self-citationGiangreco, A., Reynolds, S. D., & Stripp, B. R. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64169-7 · Cited by 544
Visualizing Gene Expression in Living Mammals Using a Bioluminescent Reporter
Contag, C. H., Spilman, S. D., Contag, P. R., Oshiro, M., Eames, B., Dennery, P., Stevenson, D. K., & Benaron, D. A. (1997) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1997.tb03184.x · Cited by 526
Id2 is a retinoblastoma protein target and mediates signalling by Myc oncoproteins
Lasorella, A., Noseda, M., Beyna, M., & Iavarone, A. (2000) · Nature · doi:10.1038/35036504 · Cited by 497
Hong, K. U., Reynolds, S. D., Giangreco, A., Hurley, C. M., & Stripp, B. R. (2001) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.24.6.4498 · Cited by 487
Rodenhuis, S., Slebos, R. J. C., Boot, A. J., Evers, S. G., Mooi, W. J., WAGENAAR, S. S., Bodegom, P. C. V., & Bos, J. L. (1988) · PubMed · Cited by 465
The myc Oncogene: arvelouslomplex
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84004-0 · Cited by 463
An achaete-scute homologue essential for neuroendocrine differentiation in the lung
Borges, M., Linnoila, R. I., van de Velde, H. J. K., Chen, H., Nelkin, B. D., Mabry, M., Baylin, S. B., & Ball, D. W. (1997) · Nature · doi:10.1038/386852a0 · Cited by 454
Reynolds, S. D., Giangreco, A., Power, J. H. T., & Stripp, B. R. (2000) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64727-x · Cited by 447
Lung Tumors in Mice: Application to Carcinogenesis Bioassay
(1975) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60970-7 · Cited by 436
Molecular genetics of small cell lung carcinoma
WISTUBA, I. (2001) · Seminars in Oncology · doi:10.1016/s0093-7754(01)90072-7 · Cited by 421
Dannenberg, J.-H., van Rossum, A., Schuijff, L., & te Riele, H. (2000) · Genes & Development · doi:10.1101/gad.847700 · Cited by 413
Wistuba, I. I., Behrens, C., Virmani, A. K., Mele, G. M., Milchgrub, S., Girard, L., Fondon, J. W., Garner, H. R., McKay, B., Latif, F., et al. (2000) · PubMed · Cited by 405
Use of Reporter Genes for Optical Measurements of Neoplastic Disease In Vivo
Contag, C. H., Jenkins, D., Contag, P. R., & Negrin, R. S. (2000) · Neoplasia · doi:10.1038/sj.neo.7900079 · Cited by 363
Clinical significance of ras oncogene activation in human lung cancer
(1993) · Lung Cancer · doi:10.1016/0169-5002(93)90536-7 · Cited by 360
Promoter Methylation and Silencing of the Retinoic Acid Receptor- Gene in Lung Carcinomas
Virmani, A. K., Rathi, A., Zochbauer-Muller, S., Sacchi, N., Fukuyama, Y., Bryant, D., Maitra, A., Heda, S., Fong, K. M., Thunnissen, F., et al. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.16.1303 · Cited by 355
p53-independent functions of the p19ARF tumor suppressor
Weber, J. D., Jeffers, J. R., Rehg, J. E., Randle, D. H., Lozano, G., Roussel, M. F., Sherr, C. J., & Zambetti, G. P. (2000) · Genes & Development · doi:10.1101/gad.827300 · Cited by 354
Girard, L., Zöchbauer‐Müller, S., Virmani, A. K., Gazdar, A. F., & Minna, J. D. (2000) · PubMed · Cited by 352
Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Reubi, J. C., Schaer, J., & Waser, B. (1997) · PubMed · Cited by 349
Hung, J. (1995) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1995.03520310056030 · Cited by 339
(1999) · PubMed · Cited by 338
Classification of Proliferative Pulmonary Lesions of the Mouse
Nikitin, A. Y., Alcaraz, A., Anver, M. R., Bronson, R. T., Cardiff, R. D., Dixon, D., Fraire, A. E., Gabrielson, E. W., Gunning, W. T., Haines, D. C., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3376 · Cited by 334 · cited 2×
“Histologic analysis of adenocarcinomas showed an equal distribution between papillary and solid subtypes (Malkinson 2001; Nikitin et al. 2004).”
Conditional Expression of Fibroblast Growth Factor-7 in the Developing and Mature Lung
Tichelaar, J. W., Lu, W., & Whitsett, J. A. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.16.11858 · Cited by 319
A Major Lung Cancer Susceptibility Locus Maps to Chromosome 6q23–25
Bailey-Wilson, J. E., Amos, C. I., Pinney, S. M., Petersen, G. M., de Andrade, M., Wiest, J. S., Fain, P., Schwartz, A. G., You, M., Franklin, W., et al. (2004) · The American Journal of Human Genetics · doi:10.1086/423857 · Cited by 316
The future worldwide health effects of current smoking patterns
Peto, R., & Lopez, A. D. (2004) · Tobacco and Public Health: Science and Policy · doi:10.1093/oso/9780198526872.003.0016 · Cited by 315
Wildtype Kras2 can inhibit lung carcinogenesis in mice
Zhang, Z., Wang, Y., Vikis, H. G., Johnson, L., Liu, G., Li, J., Anderson, M. W., Sills, R. C., Hong, H. L., Devereux, T. R., et al. (2001) · Nature Genetics · doi:10.1038/ng721 · Cited by 296
Conditional mouse models of sporadic cancer
Jonkers, J., & Berns, A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc777 · Cited by 294
Self-citationTheTP53 gene, tobacco exposure, and lung cancer
Toyooka, S., Tsuda, T., & Gazdar, A. F. (2003) · Human Mutation · doi:10.1002/humu.10177 · Cited by 276
Apoptosis-related factors p53, Bcl2, and Bax in neuroendocrine lung tumors.
Brambilla, E. M., NEGOESCU, A., Gazzéri, S., Lantuéjoul, S., Moro‐Sibilot, D., Brambilla, C., & Coll, J. (1996) · Europe PMC (PubMed Central) · Cited by 268
Autocrine growth of small cell lung cancer mediated by coexpression of c-kit and stem cell factor.
Krystal, G. W., Hines, S. J., & Organ, C. P. (1996) · PubMed · Cited by 266
The E-cadherin cell–cell adhesion complex and lung cancer invasion, metastasis, and prognosis
Bremnes, R. M., Veve, R., Hirsch, F. R., & Franklin, W. A. (2002) · Lung Cancer · doi:10.1016/s0169-5002(01)00471-8 · Cited by 246
Belinsky, S. A., Nikula, K. J., Baylin, S. B., & Issa, J. P. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4045 · Cited by 235
Sekido, Y., Bader, S., Latif, F., Chen, J. Y., Duh, F. M., Wei, M. H., Albanesi, J. P., Lee, C. C., Lerman, M. I., & Minna, J. D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.4120 · Cited by 232
Fijneman, R. J. A., de Vries, S. S., Jansen, R. C., & Demant, P. (1996) · Nature Genetics · doi:10.1038/ng1296-465 · Cited by 229
Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice.
Vooijs, M., Jonkers, J., Lyons, S. K., & Berns, A. J. M. (2002) · PubMed · Cited by 217
Self-citationConditional gene expression in the respiratory epithelium of the mouse
Perl, A.-K. T., Tichelaar, J. W., & Whitsett, J. A. (2002) · Transgenic Research · doi:10.1023/a:1013986627504 · Cited by 212
Molecular Pathogenesis of Lung Cancer
Zöchbauer-Müller, S., Gazdar, A. F., & Minna, J. D. (2002) · Annual Review of Physiology · doi:10.1146/annurev.physiol.64.081501.155828 · Cited by 209
Non-Small-Cell Lung Cancer Molecular Signatures Recapitulate Lung Developmental Pathways
Borczuk, A. C., Gorenstein, L., Walter, K. L., Assaad, A. A., Wang, L., & Powell, C. A. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63553-5 · Cited by 206
Meuwissen, R., Linn, S. C., van der Valk, M., Mooi, W. J., & Berns, A. (2001) · Oncogene · doi:10.1038/sj.onc.1204837 · Cited by 200
Self-citationOlivero, M., Rizzo, M., Madeddu, R., Casadio, C., Pennacchietti, S., Nicotra, M., Prat, M., Maggi, G., Arena, N., Natali, P., et al. (1996) · British Journal of Cancer · doi:10.1038/bjc.1996.646 · Cited by 199
Böttinger, E. P., Jakubczak, J. L., Haines, D. C., Bagnall, K. M., & Wakefield, L. M. (1997) · PubMed · Cited by 196
Graziano, S. L., Gamble, G. P., Newman, N. B., Abbott, L. Z., Rooney, M., Mookherjee, S., Lamb, M. L., Kohman, L. J., & Poiesz, B. J. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.668 · Cited by 191
Genotoxicity of environmental tobacco smoke: a review
Husgafvel-Pursiainen, K. (2004) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2004.06.004 · Cited by 186
Kitamura, H., Kameda, Y., Ito, T., & Hayashi, H. (1999) · American Journal of Clinical Pathology · doi:10.1093/ajcp/111.5.610 · Cited by 186
Onn, A., Isobe, T., Itasaka, S., Wu, W., O’Reilly, M. S., Hong, W. K., Fidler, I. J., & Herbst, R. S. (2003) · PubMed · Cited by 182
Identification of a human achaete-scute homolog highly expressed in neuroendocrine tumors.
Ball, D. W., Azzoli, C. G., Baylin, S. B., Chi, D., Dou, S., Donis-Keller, H., Cumaraswamy, A., Borges, M., & Nelkin, B. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.12.5648 · Cited by 179
Notch Signaling Induces Rapid Degradation of Achaete-Scute Homolog 1
Sriuranpong, V., Borges, M. W., Strock, C. L., Nakakura, E. K., Watkins, D. N., Blaumueller, C. M., Nelkin, B. D., & Ball, D. W. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.9.3129-3139.2002 · Cited by 172
Expression of bcl‐2 oncogene protein is prevalent in small cell lung carcinomas
Jiang, S., Sato, Y., Kuwao, S., & Kameya, T. (1995) · The Journal of Pathology · doi:10.1002/path.1711770206 · Cited by 166
Genetic polymorphisms and lung cancer susceptibility: a review
Kiyohara, C., Otsu, A., Shirakawa, T., Fukuda, S., & Hopkin, J. M. (2002) · Lung Cancer · doi:10.1016/s0169-5002(02)00107-1 · Cited by 165
Martin, B., Paesmans, M., Berghmans, T., Branle, F., Ghisdal, L., Mascaux, C., Meert, A.-P., Steels, E., Vallot, F., Verdebout, J.-M., et al. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601095 · Cited by 163
Cancer susceptibility in the mouse: genetics, biology and implications for human cancer
Demant, P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1157 · Cited by 162
Lung cancer * 9: Molecular biology of lung cancer: clinical implications
Fong, K. M., Sekido, Y., Gazdar, A. F., & Minna, J. D. (2003) · Thorax · doi:10.1136/thorax.58.10.892 · Cited by 161
Smoking molecular damage in bronchial epithelium
Wistuba, I. I., Mao, L., & Gazdar, A. F. (2002) · Oncogene · doi:10.1038/sj.onc.1205806 · Cited by 157
Molecular phenotype of airway side population cells
Giangreco, A., Shen, H., Reynolds, S. D., & Stripp, B. R. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00149.2003 · Cited by 154
Current Standards of Care in Small-Cell and Non-Small-Cell Lung Cancer
Schiller, J. H. (2001) · Oncology · doi:10.1159/000055386 · Cited by 153
The genetic basis of susceptibility to lung tumors in mice
Malkinson, A. M. (1989) · Toxicology · doi:10.1016/0300-483x(89)90062-0 · Cited by 152
Multiple Clonal Abnormalities in the Bronchial Epithelium of Patients With Lung Cancer
Park, I., Wistuba, I. I., Maitra, A., Milchgrub, S., Virmani, A. K., Minna, J. D., & Gazdar, A. F. (1999) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/91.21.1863 · Cited by 150
Hussain, S. P., Amstad, P., Raja, K., Sawyer, M., Hofseth, L. J., Shields, P. G., Hewer, A. J., Phillips, D. H., Ryberg, D., Haugen, A., et al. (2001) · PubMed · Cited by 147
Gazzéri, S., Della-Valle, V., Chaussade, L., Brambilla, C., Larsen, C., & Brambilla, E. M. (1998) · PubMed · Cited by 143
Flp-mediated tissue-specific inactivation of the retinoblastoma tumor suppressor gene in the mouse
Vooijs, M., van der Valk, M., Riele, H. T., & Berns, A. J. M. (1998) · Oncogene · doi:10.1038/sj.onc.1202169 · Cited by 140
Self-citationNotch in lung development and lung cancer
Collins, B. J., Kleeberger, W., & Ball, D. W. (2004) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2004.04.015 · Cited by 139
Ge, R., & Johnson, B. E. (1993) · PubMed · Cited by 139
Functional characterization of global genomic DNA repair and its implications for cancer
Hanawalt, P. C., Ford, J. M., & Lloyd, D. R. (2003) · Mutation Research/Reviews in Mutation Research · doi:10.1016/j.mrrev.2003.06.002 · Cited by 134
Higashiyama, M., Doi, O., Kodama, K., Yokouchi, H., Kasugai, T., Ishiguro, S., Takami, K., Nakayama, T., & Nishisho, I. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.221 · Cited by 133
Loss of the retinoblastoma protein-related p130 protein in small cell lung carcinoma
Helin, K., Holm, K., Niebuhr, A., Eiberg, H., Tommerup, N., Hougaard, S., Poulsen, H. S., Spang‐Thomsen, M., & Nørgaard, P. H. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.13.6933 · Cited by 131
A major susceptibility locus to murine lung carcinogenesis maps on chromosome 6
Gariboldi, M., Manenti, G., Canzian, F., Falvella, F. S., Radice, M. T., Pierotti, M. A., Porta, G. D., Binelli, G., & Dragani, T. A. (1993) · Nature Genetics · doi:10.1038/ng0293-132 · Cited by 130
Familial Risk of Lung Carcinoma in the Icelandic Population
Jónsson, S. (2004) · JAMA · doi:10.1001/jama.292.24.2977 · Cited by 127
The INK4a/ARF locus in murine tumorigenesis
Serrano, M. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.865 · Cited by 126
Linnoila, R. I., Zhao, B., DeMayo, J. L., Nelkin, B. D., Baylin, S. B., DeMayo, F. J., & Ball, D. W. (2000) · PubMed · Cited by 125
Masuya, D., Huang, C., Liu, D., Kameyama, K., Hayashi, E., Yamauchi, A., Kobayashi, S., Haba, R., & Yokomise, H. (2001) · Cancer · Cited by 122
Wikenheiser‐Brokamp, K. A., Clark, J. C., Linnoila, R. I., Stahlman, M. T., & Whitsett, J. A. (1992) · PubMed · Cited by 121
Perp Is a Mediator of p53-Dependent Apoptosis in Diverse Cell Types
Ihrie, R. A., Reczek, E., Horner, J. S., Khachatrian, L., Sage, J., Jacks, T., & Attardi, L. D. (2003) · Current Biology · doi:10.1016/j.cub.2003.10.055 · Cited by 118
Reissmann, P. T., Koga, H., Figlin, R. A., Holmes, E. C., & Slamon, D. J. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050243 · Cited by 118
Malkinson, A. M. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00232-4 · Cited by 112
Dang, T. P., Eichenberger, S., González, A., Olson, S. J., & Carbone, D. P. (2003) · Oncogene · doi:10.1038/sj.onc.1206230 · Cited by 110
Ratschiller, D., Heighway, J., Gugger, M., Каппелер, А., Pirnia, F., Schmid, R. A., Borner, M., & Betticher, D. C. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.03.103 · Cited by 106
Claudio, P. P., Howard, C. M., Pacilio, C., Cinti, C., Romano, G., Minimo, C., Maraldi, N. M., Minna, J. D., Gelbert, L. M., Leoncini, L., et al. (2000) · PubMed · Cited by 105
Kerkhoff, E., Fedorov, L. M., Siefken, R., Walter, A. O., Papadopoulos, T. G., & Rapp, U. R. (2000) · PubMed · Cited by 105
Omer, C. A., Chen, Z., Diehl, R. E., Conner, M. W., Chen, H. Y., Trumbauer, M. E., Gopal-Truter, S., Seeburger, G., Bhimnathwala, H., Abrams, M. T., et al. (2000) · PubMed · Cited by 105
Lung tumors in mice expressing an antisense RARβ2 transgene
Bérard, J., Laboune, F., Mukuna, M., Massé, S., Kothary, R., & Bradley, W. E. C. (1996) · The FASEB Journal · doi:10.1096/fasebj.10.9.8801172 · Cited by 104
Expression of bcl-2 — protein in small cell lung cancer
Kaiser, U., Schilli, M., Haag, U., Neumann, K., Kreipe, H. H., Коган, Е. А., & HAVEMANN, K. (1996) · Lung Cancer · doi:10.1016/0169-5002(96)00568-5 · Cited by 104
Lyons, S. K., Meuwissen, R. L. J., Krimpenfort, P., & Berns, A. J. M. (2003) · PubMed · Cited by 104
Self-citationZhang, Z., Liu, Q., Lantry, L. E., Wang, Y., Kelloff, G. J., Anderson, M. W., Wiseman, R. W., Lubet, R. A., & You, M. (2000) · PubMed · Cited by 101
Malkinson, A. M., Nesbitt, M. N., & Skamene, E. (1985) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/75.5.971 · Cited by 100
Epigenetic down-regulation of death-associated protein kinase in lung cancers.
Toyooka, S., Toyooka, K. O., Miyajima, K., Reddy, J., Toyota, M., Sathyanarayana, U. G., Padar, A., Tockman, M. S., Lam, S. C., Shivapurkar, N., et al. (2003) · PubMed · Cited by 98
Kondo, M., Ji, L., Kamibayashi, C., Tomizawa, Y., Randle, D. E., Sekido, Y., Yokota, J., Kashuba, V. I., Zabarovsky, E. R., Kuzmin, I., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204832 · Cited by 97
Molecular genetic abnormalities in the pathogenesis of human lung cancer
Forgacs, E., Zöchbauer‐Müller, S., Oláh, E., & Minna, J. D. (2001) · Pathology & Oncology Research · doi:10.1007/bf03032598 · Cited by 97
Shivapurkar, N., Virmani, A. K., Wistuba, I. I., Milchgrub, S., Mackay, B., Minna, J. D., & Gazdar, A. F. (1999) · PubMed · Cited by 95
Parental bias of Ki-ras oncogenes detected in lung tumors from mouse hybrids.
You, M., Wang, Y., Stoner, G. D., You, L., Maronpot, R. M., Reynolds, S. H., & Anderson, M. W. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5804 · Cited by 93
Proliferative Lesions of the Mouse Lung: Progression Studies in Strain A Mice
Foley, J. F., Anderson, M. W., Stoner, G. D., Gaul, B. W., Hardisty, J. F., & Maronpot, R. R. (1991) · Experimental Lung Research · doi:10.3109/01902149109064408 · Cited by 92
Dosaka‐Akita, H., Hu, S., Fujino, M., Harada, M., Kinoshita, I., Xu, H., Kuzumaki, N., Kawakami, Y., & Benedict, W. F. (1997) · PubMed · Cited by 91
Chen, B., Johanson, L., Wiest, J. S., Anderson, M. W., & You, M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.4.1589 · Cited by 89
Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer
Jarmalaitė, S., Kannio, A., Anttila, S. L., Lazutka, J. R., & Husgafvel‐Pursiainen, K. (2003) · International Journal of Cancer · doi:10.1002/ijc.11322 · Cited by 87
Tripodis, N., Hart, A. A. M., Fijneman, R. J. A., & Démant, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.19.1484 · Cited by 86
In Vitro and In Vivo Effects of a Farnesyltransferase Inhibitor onNf1-Deficient Hematopoietic Cells
Mahgoub, N., Taylor, B. R., Gratiot, M., Kohl, N. E., Gibbs, W. W., Jacks, T., & Shannon, K. (1999) · Blood · doi:10.1182/blood.v94.7.2469.419a01_2469_2476 · Cited by 86
Yatsunami, J., Tsuruta, N., Ogata, K., Wakamatsu, K., Takayama, K., Kawasaki, M., Nakanishi, Y., Hara, N., & Hayashi, S.-I. (1997) · Cancer Letters · doi:10.1016/s0304-3835(97)00296-6 · Cited by 85
Harvey, P., Warn, A., NEWMAN, P., Perry, L. J. P., Ball, R. Y., & Warn, R. M. (1996) · The Journal of Pathology · Cited by 81
Impact of Neuroendocrine Differentiation in Non-small Cell Lung Cancer
Linnoila, R. I., Piantadosi, S., & Ruckdeschel, J. C. (1994) · CHEST Journal · doi:10.1378/chest.106.6_supplement.367s · Cited by 78
Surfactant Protein C Expression in Urethane-Induced Murine Pulmonary Tumors
Mason, R. J., Kalina, M., Nielsen, L. D., Malkinson, A. M., & Shannon, J. M. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64717-7 · Cited by 77
Mori, S., Ito, G., Usami, N., Yoshioka, H., Ueda, Y., Kodama, Y., Takahashi, M., Fong, K. M., Shimokata, K., & Sekido, Y. (2004) · Cancer · doi:10.1002/cncr.20164 · Cited by 76
Nørgaard, P. H., Law, B. K., Joseph, H., Page, D. L., Shyr, Y., Mays, D., Pietenpol, J. A., Kohl, N. E., Oliff, A. I., Coffey, R. J., et al. (1999) · PubMed · Cited by 67
Wang, Y., Zhang, Z., Kastens, E., Lubet, R. A., & You, M. (2003) · PubMed · Cited by 66
Genetic Studies on Lung Tumor Susceptibility and Histogenesis in Mice
Malkinson, A. M. (1991) · Environmental Health Perspectives · doi:10.1289/ehp.9193149 · Cited by 66
Nicholson, S. A., Okby, N. T., Ma, K., Welsh, J. A., McMenamin, M. G., Travis, W. D., Jett, J. R., Tazelaar, H. D., Trastek, V. F., Pairolero, P. C., et al. (2001) · PubMed · Cited by 63
Atypical adenomatous hyperplasia of the lung
Montero, C. A., Gimferrer, J. M., & Belda, J. (2000) · Lung Cancer · doi:10.1016/s0169-5002(99)00135-x · Cited by 63
Rehm, S., Lijinsky, W., Singh, G., & Katyal, S. L. (1991) · PubMed · Cited by 60
Multiple molecular alterations in mouse lung tumors
Re, F. C., Manenti, G., Borrello, M. G., Colombo, M. P., Fisher, J. H., Pierotti, M. A., Porta, G. D., & Dragani, T. A. (1992) · Molecular Carcinogenesis · doi:10.1002/mc.2940050211 · Cited by 59
Takanami, I., Tanaka, F., Hashizume, T., et al. (1996) · European Journal of Cancer · doi:10.1016/0959-8049(95)00620-6 · Cited by 55
Ito, T., Udaka, N., Okudela, K., Yazawa, T., & Kitamura, H. (2003) · Endocrine Pathology · doi:10.1385/ep:14:2:133 · Cited by 55
Overexpression of CC10 modifies neoplastic potential in lung cancer cells.
Szabo, E. M., Goheer, A., Witschi, H. R., & Linnoila, R. I. (1998) · PubMed · Cited by 55
Induction of Squamous Cell Carcinoma in the Respiratory Tract of Mice 2
Nettesheim, P., & Hammons, A. S. (1971) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/47.3.697 · Cited by 54
PRECLINICAL AND CLINICAL MODELS OF LUNG CANCER CHEMOPREVENTION
You, M., & Bergman, G. (1998) · Hematology/Oncology Clinics of North America · doi:10.1016/s0889-8588(05)70040-x · Cited by 54
Metabolic genetic polymorphisms and susceptibility to lung cancer
Bouchardy, C., Benhamou, S., Jourenkova, N., Dayer, P., & Hirvonen, A. (2001) · Lung Cancer · doi:10.1016/s0169-5002(00)00215-4 · Cited by 54
Expression of the c-Kit receptor and its ligand SCF in non-small-cell lung carcinomas
Pietsch, T., Nicotra, M. R., Fraioli, R., Wolf, H. K., Mottolese, M., & Natali, P. G. (1998) · International Journal of Cancer · Cited by 52
Wang, M., Lemon, W. J., Liu, G., Wang, Y., Iraqi, F. A., Malkinson, A. M., & You, M. (2003) · PubMed · Cited by 50
Inhibition of Human Lung Cancer Cell Line Growth by an Anti-p185HER2 Antibody
Kern, J. A., Torney, L., Weiner, D. B., Gazdar, A. F., Shepard, H. M., & FENDLY, B. M. (1993) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb/9.4.448 · Cited by 50
Bérard, J., Gaboury, L. A., Landers, M., Repentigny, Y. D., Houle, B., Kothary, R., & Bradley, W. E. C. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06894.x · Cited by 50
Modeling the cancer patient with genetically engineered mice
Roberts, R. B., Arteaga, C. L., & Threadgill, D. W. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00032-7 · Cited by 47
Wikenheiser‐Brokamp, K. A., & Whitsett, J. A. (1997) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/ajrcmb.16.6.9191473 · Cited by 44
USE OF p53 TRANSGENIC MICE IN THE DEVELOPMENT OF CANCER MODELS FOR MULTIPLE PURPOSES
Lubet, R. A., Zhang, Z., Wiseman, R. W., & You, M. (2000) · Experimental Lung Research · doi:10.1080/01902140150216684 · Cited by 42
Phenotypic consequences of lung-specific inducible expression of FGF-3
Zhao, B., Chua, S. S., Burcin, M. M., Reynolds, S. D., Stripp, B. R., Edwards, R. A., Finegold, M. J., Tsai, S. Y., & DeMayo, F. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.101116598 · Cited by 39
Therapeutic advances in small cell lung cancer
Worden, F. P., & Kalemkerian, G. P. (2000) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.9.3.565 · Cited by 38
Prognostic factors in NSCLC. Recent experiences
van Zandwijk, N., Mooi, W. J., & Rodenhuis, S. (1995) · Lung Cancer · doi:10.1016/0169-5002(95)00418-z · Cited by 38
Doll, R. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.162.1.16221 · Cited by 38
Linnoila, R. I., Sahu, A., Miki, M., Ball, D. W., & DeMayo, F. J. (2000) · Experimental Lung Research · doi:10.1080/01902140150216693 · Cited by 38
The A/J mouse lung as a model for developing new chemointervention strategies.
Belinsky, S. A., Stefanski, S. A., & Anderson, M. W. (1993) · PubMed · Cited by 37
Driving the Cell Cycle to Cancer
Malumbres, M., Hunt, S. L., Sotillo, R., Martín‐Broto, J., Odajima, J., Martín, A., Dubus, P. R., Ortega, S., & Barbacid, M. (2003) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-0081-0_1 · Cited by 37
CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agents
Omer, C. A., & Kohl, N. E. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)01129-2 · Cited by 35
Calcitonin driven v-Ha-ras induces multilineage pulmonary epithelial hyperplasias and neoplasms
Sunday, M. E., Haley, K. J., Sikorski, K. A., Graham, S. A., Emanuel, R. L., Zhang, F., Mu, Q., Shahsafaei, A., & Hatzis, D. (1999) · Oncogene · doi:10.1038/sj.onc.1202810 · Cited by 34
Zhang, Z., Wang, Y., Lantry, L. E., Kastens, E., Liu, G., Hamilton, A. D., Sebti, S. M., Lubet, R. A., & You, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206630 · Cited by 33
Mouse Models for Sporadic Cancer
Meuwissen, R. L. J., Jonkers, J., & Berns, A. J. M. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5146 · Cited by 32
Self-citationV. Gastrointestinal peptide signaling through tyrosine phosphorylation of focal adhesion proteins
Rozengurt, E. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.2.g177 · Cited by 32
In silico p53 mutation hotspots in lung cancer
Lewis, P. D. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh068 · Cited by 30
Recent advances in the molecular diagnosis of lung cancer
Mao, L. (2002) · Oncogene · doi:10.1038/sj.onc.1205564 · Cited by 29
Prognostic factors in stage I/II non-small cell lung cancer
Junker, K. (2001) · Lung Cancer · doi:10.1016/s0169-5002(01)00298-7 · Cited by 27
Herzog, C. R., Noh, S. J., Lantry, L. E., Guan, K.-L., & You, M. (1999) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199906)25:2<92::aid-mc3>3.0.co;2-2 · Cited by 27
Miller, M. S., Gressani, K. M., Leone‐Kabler, S., Townsend, A. J., Malkinson, A. M., & O’Sullivan, M. G. (2000) · Experimental Lung Research · doi:10.1080/01902140150216774 · Cited by 27
Li, E. E., Heflich, R. H., Bucci, T. J., Manjanath, M. G., Blaydes, B. S., & Delclos, K. B. (1994) · Carcinogenesis · doi:10.1093/carcin/15.7.1377 · Cited by 27
CA1A2X-competitive inhibitors of farnesyltransferase as anti-cancer agents
Omer, C. A., & Kohl, N. E. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90677-5 · Cited by 27
A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression
Zhang, Z., Wang, Y., Herzog, C. R., Liu, G., Lee, H., DePinho, R. A., & You, M. (2002) · Oncogene · doi:10.1038/sj.onc.1205725 · Cited by 25
Investigating Stem Cells in the Lung
Magdaleno, S. M., Barrish, J. P., Finegold, M. J., & DeMayo, F. J. (1998) · Advances in Pediatrics · doi:10.1016/s0065-3101(23)00124-x · Cited by 25
Notch signalling at the crossroads of T cell development and leukemogenesis
Campese, A. F., Bellavia, D., Gulino, A., & Screpanti, I. (2003) · Seminars in Cell and Developmental Biology · doi:10.1016/s1084-9521(02)00184-2 · Cited by 22
Thaete, L. G., & Malkinson, A. M. (1990) · Cancer Letters · doi:10.1016/0304-3835(90)90190-9 · Cited by 21
Gunning, W. T., Stoner, G. D., & Goldblatt, P. J. (1991) · Experimental Lung Research · doi:10.3109/01902149109064416 · Cited by 21
Survival in small cell lung carcinoma is independent of Bcl-2 expression
Maitra, A., Amirkhan, R. H., Saboorian, M. H., et al. (1999) · Human Pathology · doi:10.1016/s0046-8177(99)90099-0 · Cited by 20
Geick, A., Redecker, P., Ehrhardt, A., Klocke, R., Paul, D., & Halter, R. (2001) · Transgenic Research · doi:10.1023/a:1013085228119 · Cited by 16
A high-resolution analysis of chromatin structure alongp53 sequences
Tornaletti, S., Bates, S., & Pfeifer, G. P. (1996) · Molecular Carcinogenesis · doi:10.1002/(sici)1098-2744(199612)17:4<217::aid-mc5>3.0.co;2-a · Cited by 15
Use of Quantitative Trait Loci to Map Murine Lung Tumor Susceptibility Genes
Devereux, T. R., & Kaplan, N. L. (1998) · Experimental Lung Research · doi:10.3109/01902149809087377 · Cited by 13
Vitolo, D., Ciocci, L., Cicerone, E., Rossi, C., Tiboni, F., Ferrauti, P., Gallo, A., & Baroni, C. D. (2001) · The Journal of Pathology · doi:10.1002/path.938 · Cited by 12
p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan
Nose, H., Imazeki, F., Ohto, M., & Omata, M. (1993) · Cancer · doi:10.1002/1097-0142(19930715)72:2
Cited by
Small-cell lung cancer: what we know, what we need to know and the path forward
Gazdar, A. F., Bunn, P. A., & Minna, J. D. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.87 · Cited by 904
Conditional mouse lung cancer models using adenoviral or lentiviral delivery of Cre recombinase
DuPage, M., Dooley, A. L., & Jacks, T. (2009) · Nature Protocols · doi:10.1038/nprot.2009.95 · Cited by 894
Sutherland, K. D., Proost, N., Brouns, I., Adriaensen, D., Song, J.-Y., & Berns, A. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.04.019 · Cited by 534
“…regulate NE cell differentiation, and thismay explain why Rb1 loss is predominately associated with SCLC. Conversely, activating mutations in K-ras are almost exclusively found in NSCLC, while Trp53 loss-of-function is observed in both SCLC and NSCLC (for review, see Meuwissen and Berns, 2005).”
BackgroundSelf-citationStearman, R. S., Dwyer-Nield, L., Zerbe, L., Blaine, S. A., Chan, Z., Bunn, P. A., Johnson, G. L., Hirsch, F. R., Merrick, D. T., Franklin, W. A., et al. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61257-6 · Cited by 312
A Translational View of the Molecular Pathogenesis of Lung Cancer
Sato, M., Shames, D. S., Gazdar, A. F., & Minna, J. D. (2007) · Journal of Thoracic Oncology · doi:10.1097/01.jto.0000263718.69320.4c · Cited by 297
Metadata
- Authors
- Meuwissen, R., & Berns, A.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2005-03-15
- Volume
- 19
- Issue
- 6
- Pages
- 643-664
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2145088924
- Cited by
- 302
- References
- 191
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.